Notification by Pareto Phone of data breach involving some Diabetes Australia (NSW and ACT) information 1 September 2023 Diabetes Australia was recently made aware of a data breach involving Pareto Phone, an Australian based telephone fundraising service provider used by many charities in Australia. We understand more than 70 Australian charities who have used Pareto have been impacted by this data breach. Diabetes Australia briefly worked with Pareto in NSW and ACT between 2018 and 2021. Regrettably, we understand that some of our NSW and ACT supporters’ information was involved in the Pareto data breach. Diabetes Australia’s own networks and systems have not been impacted in any way. We have reported Pareto Phone’s data incident to the Office of the Australian Information Commissioner. We are in the process of communicating directly with individuals affected. We are fully committed to protecting the privacy and information of our community and are deeply concerned that this incident impacting more than 70 Australian charities has happened. Our supporters and the Australian community are at the heart of everything we do. We deeply regret any concerns this incident may raise for our supporters and are fully committed to offering any necessary assistance and support. We want to reinforce that our Diabetes Australia networks and systems have not been compromised, and we maintain stringent security measures and practices. Our dedicated contact centre team is available to help on 1800 177 055 (Monday to Saturday– 8:30am to 4:30pm) or by email [email protected].
Blog 30 July 2025 Stroke awareness and prevention Stroke awareness week runs from 31 August to 6 Sept 2020 Continue Reading
News 29 July 2025 Lower PBS medicine costs to benefit Australians living with diabetes Australians living with diabetes will save money from a further reduction in the cost of prescription medicines, with the Pharmaceutical... Continue Reading
News 23 July 2025 Ozempic supply returning to normal in Australia Diabetes Australia has welcomed confirmation that the supply of Ozempic (semaglutide) in Australia has stabilised, with prescribing and supply restrictions... Continue Reading